AFP
GILD icon

Ausdal Financial Partners’s Gilead Sciences GILD Stock Holding History

Ausdal Financial Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.31M Buy
16,603
+1,088
+7% +$152K 0.1% 207
2025
Q4 		$1.9M Sell
15,515
-451
-3% -$54.8K 0.09% 228
2025
Q3 		$1.77M Buy
15,966
+3,135
+24% +$356K 0.09% 242
2025
Q2 		$1.42M Buy
12,831
+1,040
+9% +$111K 0.09% 202
2025
Q1 		$1.32M Buy
11,791
+5,208
+79% +$537K 0.1% 203
2024
Q4 		$608K Sell
6,583
-72
-1% -$6.48K 0.05% 308
2024
Q3 		$558K Sell
6,655
-266
-4% -$20.3K 0.06% 285
2024
Q2 		$475K Buy
6,921
+35
+0.5% +$2.34K 0.05% 297
2024
Q1 		$504K Sell
6,886
-815
-11% -$62.7K 0.06% 270
2023
Q4 		$624K Sell
7,701
-295
-4% -$23K 0.08% 221
2023
Q3 		$599K Buy
7,996
+577
+8% +$44.4K 0.08% 220
2023
Q2 		$572K Buy
7,419
+224
+3% +$17.9K 0.08% 222
2023
Q1 		$597K Buy
7,195
+50
+0.7% +$4.14K 0.08% 221
2022
Q4 		$613K Buy
7,145
+217
+3% +$17.2K 0.09% 214
2022
Q3 		$427K Sell
6,928
-37
-0.5% -$2.33K 0.07% 270
2022
Q2 		$430K Sell
6,965
-448
-6% -$27.7K 0.06% 284
2022
Q1 		$441K Sell
7,413
-7
-0.1% -$447 0.06% 298
2021
Q4 		$539K Sell
7,420
-341
-4% -$23.5K 0.07% 267
2021
Q3 		$542K Sell
7,761
-326
-4% -$22.9K 0.08% 261
2021
Q2 		$557K Buy
8,087
+571
+8% +$38.1K 0.08% 242
2021
Q1 		$486K Buy
7,516
+965
+15% +$62.2K 0.08% 249
2020
Q4 		$382K Buy
6,551
+1,367
+26% +$82.5K 0.07% 267
2020
Q3 		$328K Sell
5,184
-635
-11% -$44K 0.08% 244
2020
Q2 		$448K Buy
5,819
+367
+7% +$28.1K 0.15% 156
2020
Q1 		$443K Buy
5,452
+250
+5% +$17.3K 0.16% 152
2019
Q4 		$334K Sell
5,202
-1,115
-18% -$72.6K 0.1% 230
2019
Q3 		$400K Hold
6,317
– – 0.14% 187
2019
Q2 		$424K Sell
6,317
-590
-9% -$38.8K 0.16% 170
2019
Q1 		$449K Buy
6,907
+612
+10% +$40.7K 0.18% 146
2018
Q4 		$394K Sell
6,295
-949
-13% -$66.3K 0.19% 133
2018
Q3 		$559K Sell
7,244
-771
-10% -$58.2K 0.16% 172
2018
Q2 		$568K Buy
8,015
+253
+3% +$17.9K 0.18% 171
2018
Q1 		$585K Buy
7,762
+212
+3% +$16.9K 0.2% 150
2017
Q4 		$541K Sell
7,550
-50
-0.7% -$3.8K 0.19% 160
2017
Q3 		$616K Sell
7,600
-209
-3% -$16K 0.24% 122
2017
Q2 		$553K Buy
7,809
+363
+5% +$24.2K 0.24% 122
2017
Q1 		$506K Buy
7,446
+847
+13% +$59.6K 0.23% 111
2016
Q4 		$473K Sell
6,599
-1,566
-19% -$116K 0.22% 116
2016
Q3 		$646K Buy
8,165
+2,948
+57% +$239K 0.33% 89
2016
Q2 		$435K Buy
5,217
+237
+5% +$21K 0.22% 121
2016
Q1 		$457K Buy
4,980
+632
+15% +$57K 0.26% 106
2015
Q4 		$440K Buy
+4,348
New +$452K 0.22% 108

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Ausdal Financial Partners's GILD Position: Q1 2026 in Review

Ausdal Financial Partners increased its Gilead Sciences (GILD) stake by 7% in Q1 2026, buying an estimated $152K and bringing the position to 16,603 shares worth $2.31M. The position accounts for 0.1% of the portfolio, ranked #207.

Ausdal Financial Partners first reported a position in GILD in Q4 2015 and has held it in 42 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Ausdal Financial Partners held 16,603 shares of Gilead Sciences worth $2.31M as of Q1 2026.
  • Ausdal Financial Partners bought 1,088 Gilead Sciences shares in Q1 2026, an estimated $152K.
  • Gilead Sciences made up 0.1% of Ausdal Financial Partners's portfolio in Q1 2026, its #207 holding.
  • Ausdal Financial Partners first reported a position in Gilead Sciences in Q4 2015 and has held it in 42 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Ausdal Financial Partners's 13F filing for Q1 2026, filed 12 May 2026.